Journal article Open Access

Adverse effects of anticancer agents that target the VEGF pathway

Chen, Helen X.; Cleck, Jessica N.

Antiangiogenic agents that target the VEGF pathway have become an important part of standard therapy in multiple cancer indications. Although most adverse effects of VEGF inhibitors are modest and manageable, some are associated with serious and life-threatening consequences. This Review examines the toxicity profiles of anti-VEGF monoclonal antibodies and small-molecule inhibitors and considers the potential mechanisms of the adverse effects, risk factors, and the implications for patient management.

Files (432.0 kB)
Name Size
article.pdf
md5:a7d0ea826813257208ff06503d1c294e
432.0 kB Download
51
75
views
downloads
Views 51
Downloads 75
Data volume 32.4 MB
Unique views 47
Unique downloads 69

Share

Cite as